North America Spatial Genomics & Transcriptomics Market Size & Outlook
- Biotechnology
- Genomics & Genetic Engineering
- Spatial Genomics & Transcriptomics Market Outlook
- Genomics & Genetic Engineering
North America Spatial Genomics Transcriptomics Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the spatial genomics & transcriptomics market
North America spatial genomics & transcriptomics market highlights
- The North America spatial genomics & transcriptomics market generated a revenue of USD 135.5 million in 2023.
- The market is expected to grow at a CAGR of 10.2% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 135.5 million |
| Market revenue in 2030 | USD 266.6 million |
| Growth rate | 10.2% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
Other key industry trends
- In terms of revenue, North America region accounted for 43.7% of the global spatial genomics & transcriptomics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 139.0 million by 2030.
Increasing prevalence of cancer, growing demand for personalized medicine, well-developed healthcare facilities, and availability of novel diagnostic techniques can be attributed to the large market share held by North America. Growing morbidity and mortality rates due to cancer and other metabolic, autoimmune, & inflammatory disorders have led to an increase in need for developing novel therapies, thereby driving the market in this region.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Spatial Genomics & Transcriptomics Market Scope
Spatial Genomics Transcriptomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Natera Inc | View profile | 3,293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | www.natera.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | www.horizondiscovery.com |
| Dovetail Genomics | View profile | 11-50 | Scotts Valley, California, United States, North America | dovetailgenomics.com/ |
| NanoString Technologies | View profile | 251-500 | Seattle, Washington, United States, North America | www.nanostring.com |
| Seven Bridges | View profile | 251-500 | Charlestown, Massachusetts, United States, North America | www.sevenbridges.com/ |
| S2 Genomics | View profile | 11-50 | Livermore, California, United States, North America | s2genomics.com |
North America Spatial Genomics & Transcriptomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Spatial Genomics & Transcriptomics Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.69% in 2023.
Horizon Databook has segmented the North America spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of cancer, growing demand for personalized medicine, well-developed healthcare facilities, and availability of novel diagnostic techniques can be attributed to the large market share held by North America. Growing morbidity and mortality rates due to cancer and other metabolic, autoimmune, & inflammatory disorders have led to an increase in need for developing novel therapies, thereby driving the market in this region.
- North America Spatial Genomics & Transcriptomics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Instruments
- Consumables
- Software
- North America Spatial Genomics & Transcriptomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Spatial Transcriptomics
- Spatial Genomics
- North America Spatial Genomics & Transcriptomics Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Translational Research
- Academic Customers
- Diagnostic Customers
- Pharmaceutical Manufacturer
Reasons to subscribe to Spatial Genomics & Transcriptomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spatial Genomics & Transcriptomics Market Outlook databook
- Our clientele includes a mix of Spatial Genomics & Transcriptomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Spatial Genomics & Transcriptomics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Spatial Genomics & Transcriptomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
North America Spatial Genomics Transcriptomics Market, 2018-2030 (US$M)
North America spatial genomics & transcriptomics market statistics, by product, 2018-2030 (US$M)
